France· FR:69328782
BEROMUN 1 mg, poudre pour solution pour perfusion
A tasonermin product containing tasonermine, registered in France by BELPHARMA (LUXEMBOURG). The same ATC class is registered in 10 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Tasonermin is registered in 10 of 19 countries.
Countries holding a registration under ATC L03AX11 (tasonermin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Tasonermin · ATC L03AX11
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TASONERMINE
- Manufacturer
- BELPHARMA (LUXEMBOURG)
- Country
- France (FR)
- ATC code
- L03AX11
- ATC class
- Tasonermin
- Defined daily dose
- 3.5 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400956165797flacon (verre) - Boîte de 4 flacons
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tasonermin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenBEROMUN 1 mg Pulver och vätska till infusionsvätska, lösningBELPHARMA s.a.
- United KingdomBeromun 1mg powder and solvent for solution for infusion vialsBoehringer Ingelheim Ltd
- SpainBEROMUN 1 mg POLVO PARA SOLUCION PARA PERFUSIONBelpharma S.A.
- FinlandBeromunBELPHARMA s.a.
- BelgiumBeromun 1 mgBelpharma
- IcelandBeromunBELPHARMA s.a.
- NetherlandsBeromun 1 mg poeder voor oplossing voor infusieBelpharma s.a.
- PolandBeromunBELPHARMA s.a.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Beromun
- Liechtenstein · Beromun
- Norway · Beromun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/683ddc0c-0700-48b0-9457-6ecb02b08277 GET /v1/drugs/683ddc0c-0700-48b0-9457-6ecb02b08277?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69328782",
"date_amm": "1999-04-13",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/99/097",
"substance": "TASONERMINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution pour perfusion",
"voies_administration": "intraartérielle",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tasonermin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.